Skip to main content
SpringerLink
Log in

Health and safety in industry labs

  • Q&A
  • Published:

From Nature Chemistry

View current issue Submit your manuscript

Dave Laffan, a Director in Chemical Development at AstraZeneca, talks to Nature Chemistry about safety in industry labs and his role on the Safety, Health and Environment committee.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Nature Chemistry https://www.nature.com/naturechemistry

    Katherine Geogheghan

Authors
  1. Katherine Geogheghan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Katherine Geogheghan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Geogheghan, K. Health and safety in industry labs. Nat. Chem. 12, 8–10 (2020). https://doi.org/10.1038/s41557-019-0401-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41557-019-0401-z

  • Springer Nature Limited

Search

Navigation